|
|
| (529 intermediate revisions by 32 users not shown) |
| Line 1: |
Line 1: |
| | {{ACM}} {{SemRikken}} |
|
| |
|
|
| |
|
| [[Sandbox#Antiretroviral drug toxicities and quality of life|testing]]
| | ''SANDBOX'' |
| | | [[File:Captura de Pantalla 2024-05-18 a la(s) 9.33.11 p.m..png]] |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| #'''===Antiretroviral drug toxicities and quality of life==='''
| |
| ## PI
| |
| ###
| |
| #
| |
| #
| |
| | |
| Earlier initiation of ART extends exposure to ARV agents by several years. The D:A:D study found an increased incidence of CVD associated with cumulative exposure to some drugs in the [[nucleoside reverse transcriptase inhibitor]] (NRTI) and [[PI]] drug classes.
| |
| | |
| [[Sandbox#top|back to top]]
| |
Latest revision as of 21:12, 21 October 2024
_9.33.11_p.m..png)